首页 > Biosensis > Biosensis/Sheep antibody to alpha synuclein (108-120): affinity purified/S-078-50/50 µg

提醒：代购产品，无质量问题不接受退换货，下单前请仔细核对信息。下单后请及时联系客服核对商品价格，订单生效后再付款。

Biosensis/Sheep antibody to alpha synuclein (108-120): affinity purified/S-078-50/50 µg

价格：

登录查看

自营商城

解放采购

正品保障

及时交付

厂家直采

一站服务

货号：

S-078-50

品牌：

Biosensis

会员服务：

尊享会员价

贵宾专线

运费优惠

闪电退款

福利优惠

上门换新

友情提示

以上价格仅为参考，请联系客服询价。

免费咨询热线

4000-520-616

产品说明

Description Alpha synuclein is an abundant 140 amino acid neuronal protein, expressed primarily at presynaptic terminals in the central nervous system. Alpha synuclein has been associated with several neurodegenerative diseases. A point mutation in the gene coding for the alpha-synuclein protein was the first discovery linking this protein to a rare familial form of Parkinson's disease (PD). Subsequently, other mutations in the alpha-synuclein gene have been identified in familial PD. The aggregated proteinaceous inclusions called Lewy bodies found in PD and cortical Lewy body dementia (LBD) were discovered to be predominantly alpha-synuclein. Aberrant aggregation of alpha-synuclein has been detected in an increasing number of neurodegenerative diseases, collectively known as synucleopathies. Alpha-synuclein exists physiologically in both soluble and membrane-bound states, in unstructured and alpha-helical conformations, respectively. The physiological function of alpha-synuclein appears to require its translocation between these subcellular compartments and interconversion between the 2 conformations. Abnormal processing of alpha-synuclein is predicted to lead to pathological changes in its binding properties and function. Batch No. See product label Unit size 50 µg Antigen A synthetic peptide (PQEGILEDMPVDPC) of human alpha synuclein protein (aa: 108-120) conjugated to diphtheria toxoid has been used as the immunogen. Other Names Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP Accession SYUA_HUMAN Produced in Sheep Purity Affinity purified and dialysed against PBS. Contains 0.02% sodium azide. Applications IHC. Recommended to be used at a concentration of 1 µg/ml for immunohistochemistry (Paraffin sections). Biosensis recommends optimal dilutions/concentrations should be determined by the end user. Specificity Immunihistochemical analysis of human and rat brain indicates a high level of specificity for this antiserum. Specificity was also confirmed by western blot. Cross-reactivity This antiserum is known to react with human and rat alpha synuclein. Blast it If you would like to use this product in another species other than those specified here, or to see the shared identity between the immunogen used here in different speices and/or other molecules, simply copy the immunogen (from the Immunogen field) and paste it HERE and blast/format it. Note that, antisera raised against synthetic peptides are quite often very specific for that peptide ie, only one single amino acid difference may be enough to restrict the specificity to a particular molecule. Regardless, you can always contact us if you need assistance with this. Form Lyophilised Reconstitution Reconstitute in 50 µl of sterile water. Centrifuge to remove any insoluble material. Storage After reconstitution keep aliquots at -20ºC for a higher stability, and at 4ºC with an appropriate antibacterial agent. Glycerol (1:1) may be added for an additional stability. Avoid repetitive freeze/thaw cycles. Expiry Date 12 months after purchase References 1. Lundvig, et al Brain Res Mol Brain Res 134, 3-17 (Mar 24, 2005). 2. Bennett, Pharmacol Ther 105, 311-31 (Mar, 2005). 3. Vekrellis, et al., Mol Neurobiol 30, 1-21 (Aug, 2004). 4. Martin, et al., Protein Pept Lett 11, 229-37 (Jun, 2004). 5. Doherty, et al., Acta Neuropathol (Berl) 107, 169-75 (Feb, 2004). 6. Goedert, Curr Opin Genet Dev 11, 343-51 (Jun, 2001). 7. Saito, et al., J Neurol Sci 177, 48-59 (Aug 1, 2000). 8. Lucking et al. Cell Mol Life Sci. 2000 Dec;57(13-14):1894-908. 9. Kahle, et al., Ann N Y Acad Sci 920, 33-41 (2000). 10. Clayton, et al., Trends Neurosci 21, 249-54 (Jun, 1998).

Biosensis是一家由生命科学家和商业团队组成的公司，致力于为全球学术界和工业界的研究人员提供支持。该团队在基础和应用生命科学研究方面拥有超过100年的经验，并在生命科学研究和诊断市场的生命科学抗体，试剂和试剂盒的商业化方面拥有50多年的经验。